Chartwell Investment Partners, LLC Mirum Pharmaceuticals, Inc. Transaction History

Chartwell Investment Partners, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 26, 2022	SELL	$15.5 - $23.93 $1.42 Million - $2.19 Million	-91,490 Closed	0 $0
Q4 2021 Feb 15, 2022	BUY	$13.05 - $19.35 $330,308 - $489,767	25,311 Added 38.25%	91,490 $1.46 Million
Q2 2021 Jul 19, 2021	BUY	$15.84 - $20.6 $9,424 - $12,257	595 Added 0.91%	66,179 $1.14 Million
Q1 2021 May 03, 2021	SELL	$16.29 - $21.92 $57,405 - $77,246	-3,524 Reduced 5.1%	65,584 $1.3 Million
Q4 2020 Feb 09, 2021	BUY	$15.75 - $25.45 $372,093 - $601,256	23,625 Added 51.94%	69,108 $1.21 Million
Q3 2020 Nov 16, 2020	BUY	$18.4 - $26.59 $522,063 - $754,438	28,373 Added 165.83%	45,483 $876,000
Q2 2020 Jul 29, 2020	BUY	$11.51 - $20.97 $196,936 - $358,796	17,110 New	17,110 $333,000

227

55M

27.4K

105K

Ticker MIRM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,751,700
Market Cap $1.66B
Description
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...

Get notified when there are updates to the investment portfolio of Chartwell Investment Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Chartwell Investment Partners, LLC with notifications on news.